Bright Health Group, Inc. (BHG)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Bright Health Group, Inc. (BHG) trades at $16.35. Bright Health Group, Inc. operates as a healthcare company, providing health insurance policies across the United States. Market cap: $130.51M, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for BHG: BHG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BHG against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BHG: 1/1 perspectives are bearish.
How is this calculated? →Bright Health Group, Inc. (BHG) Healthcare & Pipeline Overview
Bright Health Group, Inc. (BHG) offers health insurance and clinical care services in the U.S., operating through its NeueHealth and Bright HealthCare segments. The company distinguishes itself through integrated care delivery and a network of care provider partners, serving commercial and Medicare markets across multiple states.
What Is the Investment Thesis for BHG?
Bright Health Group presents a complex investment case. The company's focus on integrated care delivery through its NeueHealth segment and health plan offerings via Bright HealthCare aims to capitalize on the growing demand for coordinated and value-based care. However, the company's negative profit margin of -10.7% raises concerns about its profitability. Key growth catalysts include expansion into new markets and increased penetration within existing markets. Investors should closely monitor the company's ability to improve its financial performance and achieve sustainable profitability. The current P/E ratio is -0.62, reflecting the company's current earnings challenges.
Based on FMP financials and quantitative analysis
BHG Key Highlights
- Market capitalization of $130.51M, indicating its size relative to other players in the healthcare sector.
- Negative P/E ratio of -0.62, reflecting current losses and potential challenges in achieving profitability.
- Profit margin of -10.7%, highlighting the need for improved cost management and revenue generation.
- Gross margin of 24.2%, suggesting potential for profitability if operating expenses are managed effectively.
- Beta of 0.94, indicating that the stock's price is slightly less volatile than the overall market.
Who Are BHG's Competitors?
BHG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATYR aTyr Pharma, Inc. | $0.62 | +4.96% | $60.98M | — |
| GRAY Graybug Vision, Inc. | $5.50 | -10.80% | $120.98M | 44 |
| GTH Genetron Holdings Limited | $4.03 | +0.12% | $127.29M | 61 |
| KNTE Kinnate Biopharma Inc. | $2.65 | -0.38% | $124.99M | 45 |
| NGM NGM Biopharmaceuticals | $1.54 | -1.28% | $128.53M | 49 |
| NEGXF NexgenRx Inc. | $0.33 | -0.00% | $23.11M | 53 |
| GTS Triple-S Management Corporation | $35.99 | +1.04% | 52 | |
| ALHC Alignment Healthcare, Inc. | $24.56 | +3.19% | $5.08B | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BHG's Key Strengths?
- Integrated care delivery system through NeueHealth.
- Network of care provider partners.
- Commercial and Medicare health plan offerings.
- Presence in multiple states and markets.
What Are BHG's Weaknesses?
- Negative profit margin.
- Reliance on specific geographic markets.
- Intense competition in the healthcare industry.
- Relatively new company compared to established players.
What Could Drive BHG Stock Higher?
- Expansion of NeueHealth's clinic network to new locations, enhancing service accessibility.
- Continued efforts to improve member engagement and retention in Bright HealthCare.
- Implementation of new technologies to streamline operations and enhance member experience.
What Are the Key Risks for BHG?
- Financial-distress signal — its Altman Z-Score of -4.68 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
- Regulatory changes impacting the healthcare industry and health insurance plans.
- Increased competition from established players in the healthcare market.
- Negative profit margin and challenges in achieving profitability.
- Economic downturn affecting consumer spending on healthcare.
What Are the Growth Opportunities for BHG?
- Expansion of NeueHealth's Integrated Care Delivery System: Bright Health has the opportunity to expand its network of owned and affiliated clinics, enhancing its ability to provide coordinated care. The market for integrated care delivery is growing as patients seek more convenient and comprehensive healthcare services. By increasing the number of clinics and expanding service offerings, NeueHealth can attract more patients and improve health outcomes. This expansion can be achieved through strategic acquisitions and partnerships with existing healthcare providers. The timeline for this growth is ongoing, with continuous efforts to add new clinics and services.
- Increased Penetration in Existing Bright HealthCare Markets: Bright Health can increase its market share in the 14 states and 99 markets where it currently offers health plans. This can be achieved through targeted marketing campaigns, improved member engagement, and competitive pricing strategies. The market for commercial and Medicare health plans is large and growing, presenting significant opportunities for Bright Health to expand its customer base. The timeline for this growth is ongoing, with continuous efforts to attract new members and retain existing ones.
- Leveraging Technology to Enhance Member Experience: Bright Health can leverage technology to improve the member experience and streamline operations. This includes developing mobile apps, implementing telehealth solutions, and using data analytics to personalize care. The market for healthcare technology is rapidly expanding, with increasing demand for digital health solutions. By investing in technology, Bright Health can differentiate itself from competitors and attract tech-savvy consumers. The timeline for this growth is ongoing, with continuous efforts to develop and implement new technologies.
- Strategic Partnerships with Healthcare Providers: Bright Health can form strategic partnerships with healthcare providers to expand its network and improve access to care. This includes partnering with hospitals, physician groups, and specialty clinics. The market for healthcare partnerships is growing as providers seek to improve care coordination and reduce costs. By forming strategic partnerships, Bright Health can enhance its value proposition and attract more members. The timeline for this growth is ongoing, with continuous efforts to identify and develop new partnerships.
- Expansion into New Geographic Markets: Bright Health has the opportunity to expand its health plan offerings into new geographic markets. This can be achieved through strategic acquisitions, partnerships, and organic growth. The market for health insurance is large and fragmented, presenting significant opportunities for Bright Health to expand its reach. By entering new markets, Bright Health can diversify its revenue streams and reduce its reliance on existing markets. The timeline for this growth is dependent on regulatory approvals and market conditions.
What Opportunities Does BHG Have?
- Expansion into new geographic markets.
- Increased penetration in existing markets.
- Leveraging technology to enhance member experience.
- Strategic partnerships with healthcare providers.
What Threats Does BHG Face?
- Regulatory changes in the healthcare industry.
- Increased competition from established players.
- Economic downturn affecting consumer spending on healthcare.
- Rising healthcare costs.
What Are BHG's Competitive Advantages?
- Integrated care delivery system through NeueHealth, providing coordinated care.
- Network of care provider partners, enhancing access to care.
- Proprietary technology platform for managing health plans and delivering care.
What Does BHG Do?
Bright Health Group, Inc., established in 2015 and headquartered in Minneapolis, Minnesota, is a healthcare company focused on delivering and financing healthcare. The company operates through two primary segments: NeueHealth and Bright HealthCare. The NeueHealth segment provides virtual and in-person clinical care services through owned and affiliated primary care clinics. This segment focuses on delivering coordinated care to patients under various contracts. As of December 31, 2021, NeueHealth collaborated with approximately 260,000 care provider partners and operated 180 managed and affiliated risk-bearing clinics. These clinics offer integrated services, including pharmacy, laboratory, radiology, and population health-focused specialty care. The Bright HealthCare segment offers commercial and Medicare health plan products to consumers across 14 states and 99 markets. These plans provide individuals and families with access to healthcare services through a network of providers. Bright Health Group aims to create a more connected and affordable healthcare experience. Formerly known as Bright Health Inc., the company changed its name to Bright Health Group, Inc. in February 2021, reflecting its broader strategic focus on integrated healthcare delivery and insurance.
What Products and Services Does BHG Offer?
- Provide commercial health insurance plans to individuals and families.
- Offer Medicare health plan products to eligible beneficiaries.
- Deliver virtual clinical care services through telehealth platforms.
- Operate in-person primary care clinics.
- Manage a network of care provider partners.
- Provide integrated care delivery services, including pharmacy, laboratory, and radiology.
How Does BHG Make Money?
- Generate revenue through premiums from health insurance plans.
- Earn revenue from providing clinical care services through owned and affiliated clinics.
- Manage healthcare costs through coordinated care and risk-bearing arrangements.
What Industry Does BHG Operate In?
The healthcare industry is undergoing significant transformation, driven by increasing demand for value-based care, technological advancements, and regulatory changes. Bright Health Group operates within the medical healthcare plans segment, which is characterized by intense competition and evolving consumer expectations. The industry is experiencing growth in telehealth and virtual care solutions, aligning with Bright Health's NeueHealth segment. Competitors are focusing on expanding their networks, enhancing member experiences, and leveraging data analytics to improve health outcomes. Bright Health's integrated care model positions it to capitalize on the shift towards coordinated and personalized healthcare.
Who Are BHG's Key Customers?
- Individuals and families seeking commercial health insurance plans.
- Medicare-eligible individuals seeking Medicare Advantage plans.
- Patients seeking primary care and virtual care services.
Net buyingInsider Activity
The most recent 12 insider filings for Bright Health Group, Inc. break down as 2 sales and 10 purchases. On net that is roughly 1.6M shares acquired (about $139K) — insiders putting money in tends to read as conviction.
Quarterly Financial Performance: Bright Health Group, Inc.
Revenue for Bright Health Group, Inc. came in at $209.1M during Q2 2025, a 3.1% contraction versus the preceding quarter. The company recorded a net loss of $23.5M, with diluted EPS of $-2.62. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, BHG averaged $26.78 in diluted EPS.
BHG Valuation & Market Position
With a $130.51M market cap, Bright Health Group, Inc. sits in the micro-cap segment of the market.
ROE 6%Key Financial Metrics
Return on equity for Bright Health Group, Inc. stands at 5.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -3.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -84.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.70 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -41.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
Bright Health Group, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of -4.68 places it in the distress zone, a signal of elevated financial risk.
2/8 beatsEarnings Track Record
Bright Health Group, Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 95.2% below estimates on average.
Company Profile
Bright Health Group, Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Minneapolis, US. The company is led by CEO George Lawrence Mikan III. BHG has traded publicly since 2021.
BHG Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Integrated care delivery system through NeueHealth.
- Network of care provider partners.
- Commercial and Medicare health plan offerings.
- Presence in multiple states and markets.
Bear Case
- Negative profit margin.
- Reliance on specific geographic markets.
- Intense competition in the healthcare industry.
- Relatively new company compared to established players.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | $209M | -$24M | -$2.62 |
| Q1 2025 | $216M | -$25M | -$2.90 |
| Q4 2024 | $76M | $997M | $121.16 |
| Q3 2024 | $233M | -$70M | -$8.51 |
Based on FMP financials and quantitative analysis
BHG Latest News
No recent news available for BHG.
BHG Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BHG.
Price Targets
Wall Street price target analysis for BHG.
BHG MoonshotScore
What does this score mean?
The MoonshotScore rates BHG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: George Lawrence Mikan III
CEO
George Lawrence Mikan III serves as the CEO of Bright Health Group, Inc. His leadership is pivotal in guiding the company's strategic direction and operational execution. Information regarding his detailed career history, education, and previous roles is not available in the provided data. However, as CEO, he is responsible for overseeing the company's two segments, NeueHealth and Bright HealthCare, and driving its mission to deliver and finance healthcare.
Track Record: Information regarding George Lawrence Mikan III's specific achievements, strategic decisions, and company milestones under his leadership is not available in the provided data. His role involves managing a workforce of 2840 employees and navigating the complexities of the healthcare industry.
Bright Health Group, Inc. Healthcare Stock: Key Questions Answered
What does Bright Health Group, Inc. do?
Bright Health Group, Inc. operates as a healthcare company, focusing on delivering and financing healthcare through its two segments: NeueHealth and Bright HealthCare. NeueHealth provides virtual and in-person clinical care services through owned and affiliated primary care clinics. Bright HealthCare offers commercial and Medicare health plan products to consumers in multiple states. The company aims to provide integrated and coordinated care to improve health outcomes and reduce costs. Bright Health's business model revolves around managing healthcare costs through coordinated care and risk-bearing arrangements.
What do analysts say about BHG stock?
Analyst consensus on Bright Health Group, Inc. is not available in the provided data. However, key valuation metrics such as market capitalization, P/E ratio, and profit margin provide insights into the company's financial performance. The company's growth considerations include its ability to expand its market share, improve its profitability, and navigate the competitive healthcare landscape. Investors should conduct their own research and consider various factors before making investment decisions. The company's current P/E ratio is -0.62, reflecting the company's current earnings challenges.
What are the main risks for BHG?
Bright Health Group, Inc. faces several risks, including regulatory changes in the healthcare industry, increased competition from established players, and challenges in achieving profitability. The company's negative profit margin poses a significant risk, requiring improved cost management and revenue generation. Economic downturns could also affect consumer spending on healthcare, impacting the company's revenue. Additionally, the company's reliance on specific geographic markets exposes it to regional economic and regulatory risks. These risks should be carefully considered by investors.
What are the key factors to evaluate for BHG?
Evaluate BHG on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does BHG data refresh on this page?
BHG prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BHG's recent stock price performance?
Bright Health Group, Inc. (BHG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated care delivery system through NeueHealth. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BHG overvalued or undervalued right now?
Valuing Bright Health Group, Inc. (BHG) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying BHG?
Before investing in Bright Health Group, Inc. (BHG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Analyst consensus and future projections are subject to change.
- This is a research platform, not investment advice. Consult a financial professional for personalized advice.